Coronavirus

Pandemic Linked with Decrease in Patients Receiving Buprenorphine for OUD
Concurrent with a rise in opioid overdose deaths, fewer new patients received buprenorphine prescriptions for the treatment of opioid use disorder during the early months of the COVID-19 pandemic, according to researchers at Princeton University.
FORE Awards Grants to Assess COVID-19 Impact on OUD Treatment
The Foundation for Opioid Response Efforts is providing $1.3 million in grants for six organizations to assess temporary regulatory relaxations and policy changes that were enacted to ease access to treatment for opioid use disorder without in-person interactions in response to the COVID-19 pandemic.
Perspectives
Countering the Quieter Crisis: Addressing Staff Burnout and Strain
As the next wave of the COVID-19 pandemic arrives, it’s crucial for providers to enact staff rounding programs to understand the evolving concerns of their employees.
Perspectives
Stopping the 'Other' Surge: Addressing Rise in OUD Rates Amid Pandemic
While providers wait for vaccines to slow the COVID-19 pandemic and better treatments to reduce the death toll among those infected, there are steps that can be taken to help address the “other” surge—in the opioid crisis.
TCIV: M&A Firm ‘Extremely Bullish’ on Deals in 2021
An increase in demand for treatment services and stockpiles of dollars for private equity investors who are itching to spend could spark a hotbed of M&A activity in the behavioral health sector, particularly for substance use disorder treatment providers, Braff Group president Dexter Braff told TCIV attendees.
Panel: Isolation, Staff Safety and Licensing Among Issues Being Navigated During Pandemic
Concerns over patient isolation, staff safety and licensing reciprocity between states as a means to address a shortage of care providers during a crisis were among the COVID-19-related topics discussed by a panel of industry leaders during a Friday morning session at the virtual National Conference on Addiction Disorders.
Taking Stock of COVID-Fueled Trends That Are Shaping Behavioral Healthcare
Issues around in-person reopenings, insurance dynamics and staff turnover are among the factors playing a role in the current state of behavioral health.
An Optimistic Ode to Future Joy in the Present Sorrows of the Pandemic
Although psychiatry had traditionally focused on the mentally troubled and the troubling aspects of people, there has been a movement toward a more positive psychology and psychiatry in recent years.
Report: Researchers Studying Naltrexone for Treatment of COVID-19 Symptoms
Researchers from Beaumont Health System in Michigan are studying whether naltrexone can be used to help manage symptoms of individuals with a COVID-19 infection, according to a report from Detroit’s NPR affiliate.
Reasonable Expectations, Educated Guesses: Projecting Behavioral Healthcare's Future Amidst COVID-19
It's a difficult task with so many unknowns still surrounding the COVID-19 pandemic, but we must look forward to start planning for the state of the behavioral healthcare field, both in the immediate future and years from now.
NCAD Goes Virtual in 2020
In lieu of the two annual NCAD meetings (East and West), this year’s event will take place as a virtual experience that includes video content and live streaming with Q&A sessions July 30-Aug. 2.
Back to Top